Abstract
New technologies which involve minimal invasive procedures are creating new
orthopedic reconstructive markets. Less invasive techniques has led to
patients becoming more comfortable with surgical procedures. The market for
hip implants is being driven by an aging global population and also increased
adoption by the younger patients.
The major players in the orthopedic implant
market are Biomet, DePuy, Smith & Nephew, Stryker, and Zimmer. These five
companies have a combined share of more than 85% of the orthopedic implant
market. Hip resurfacing is turning out to be a major growth opportunity, with
FDA approval of Birmingham Hip Resurfacing (BHR) by Smith & Nephew and an
alternative hip resurfacing system made by Corin Group and marketed by
Stryker.
The report begins with a discussion of the hip replacement
technologies and then goes on to analyze the worldwide hip implant market. The
report profiles the major companies, focusing in-depth on their business
strategies. The section on competitive landscape analyses the market share and
revenues of key players in the worldwide and the US market.
View Cart
